Abstract
Summary
Injections of a potent preparation of Thymidine in doses equivalent to at least 20, 47, and 80 μg of Vit. B12 were without effect in producing hematologic improvement in patients with tropical sprue in relapse.
The thymidine used in this study was purchased from Nutritional Biochemicals Corporation.
Get full access to this article
View all access options for this article.